These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5507253)

  • 1. Complement as a factor in arteriosclerosis.
    Geertinger P; Sorensen H
    Acta Pathol Microbiol Scand A; 1970; 78(3):284-8. PubMed ID: 5507253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complement as a factor in arteriosclerosis].
    Geertinger P; Sorensen H
    Nord Med; 1970 May; 83(19):588-90. PubMed ID: 5426426
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of factor B and C3 in guinea pig serum by zymosan or by activated properdin depends on the presence of factor D.
    Brade V; Bentley C; Kossorotow A; Bitter-Suermann D
    Monogr Allergy; 1977; 12():83-5. PubMed ID: 917024
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new C3NeF assay with zymosan-treated guinea-pig serum].
    Ohmori F; Ohi H; Seki M; Watanabe S; Hatano M
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1423-7. PubMed ID: 3820819
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of zymosan-air-pouch inflammation in rats and its characterization with reference to the effects of anticomplementary and anti-inflammatory agents.
    Konno S; Tsurufuji S
    Br J Pharmacol; 1983 Oct; 80(2):269-77. PubMed ID: 6652379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum factors affecting the incorporation of (3H)thymidine by lymphocytes stimulated by antigen. 3. Evidence for a role of complement from studies with specific complement inhibitors.
    Forsdyke DR
    Immunology; 1973 Oct; 25(4):613-9. PubMed ID: 4753402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vitamin D2-induced arteriosclerosis in rats by depletion of complement with cobra venom factor.
    Pang AS; Minta JO
    Artery; 1980; 7(2):109-22. PubMed ID: 7000037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement system of man. I.
    Ruddy S; Gigli I; Austen KF
    N Engl J Med; 1972 Sep; 287(10):489-95. PubMed ID: 4114930
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement activation alters myocellular sodium homeostasis during polymicrobial sepsis.
    Wang W; Okamoto K; Jacobs DO
    Crit Care Med; 2002 Mar; 30(3):684-91. PubMed ID: 11990934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement factors and the growth of Ehrlich's carcinoma.
    Thunold S; Horseide V; Hartveit F
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):373-81. PubMed ID: 4130388
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Schenkein HA; Ruddy S
    J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation, activities and pharmacologically active products of complement.
    Vogt W
    Pharmacol Rev; 1974 Jun; 26(2):125-69. PubMed ID: 4609350
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticomplement activity of lysine complexes of propolis phenolic constituents and their synthetic analogs.
    Georgieva P; Ivanovska N; Bankova V; Popov S
    Z Naturforsch C J Biosci; 1997; 52(1-2):60-4. PubMed ID: 9090067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of calcific athero-arteriosclerosis and thromboarteritis with nicotine, vitamin D and dietary cholesterol.
    Hass GM; Landerholm W; Hemmens A
    Am J Pathol; 1966 Oct; 49(4):739-71. PubMed ID: 5924024
    [No Abstract]   [Full Text] [Related]  

  • 16. Probably role of excesses of vitamin D in genesis of arteriosclerosis.
    Peng SK; Taylor CB
    Paroi Arterielle; 1980; 6(2):63-7. PubMed ID: 7232027
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple method for the rapid production of atherosclerosis in rats.
    Altman RF
    Experientia; 1973 Feb; 29(2):256. PubMed ID: 4632573
    [No Abstract]   [Full Text] [Related]  

  • 18. Eicosanoid-mediated increase in glucose and lactate output as well as decrease and redistribution of flow by complement-activated rat serum in perfused rat liver.
    Muschol W; Püschel GP; Hülsmann M; Jungermann K
    Eur J Biochem; 1991 Mar; 196(2):525-30. PubMed ID: 2007411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.
    Baker PJ; Osofsky SG
    Clin Exp Immunol; 1981 Mar; 43(3):549-56. PubMed ID: 6912799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of heat-labile serum factors on vitamin D-induced arteriosclerosis in mice.
    Geertinger P; Strannegård O; Sorensen H
    Acta Pathol Microbiol Scand A; 1970; 78(6):729-33. PubMed ID: 5499391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.